237 related articles for article (PubMed ID: 26838046)
1. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
[TBL] [Abstract][Full Text] [Related]
3. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation.
Braeuning A; Heubach Y; Knorpp T; Kowalik MA; Templin M; Columbano A; Schwarz M
Toxicol Sci; 2011 Sep; 123(1):113-22. PubMed ID: 21705713
[TBL] [Abstract][Full Text] [Related]
5. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
[TBL] [Abstract][Full Text] [Related]
6. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
[TBL] [Abstract][Full Text] [Related]
7. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
Rignall B; Braeuning A; Buchmann A; Schwarz M
Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
[TBL] [Abstract][Full Text] [Related]
8. β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice.
Kuwata K; Inoue K; Ichimura R; Takahashi M; Kodama Y; Shibutani M; Yoshida M
Toxicol Pathol; 2017 Jun; 45(4):493-505. PubMed ID: 28580885
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of β-catenin signaling by phenobarbital in hepatoma cells in vitro.
Groll N; Petrikat T; Vetter S; Wenz C; Dengjel J; Gretzmeier C; Weiss F; Poetz O; Joos TO; Schwarz M; Braeuning A
Toxicology; 2016 Aug; 370():94-105. PubMed ID: 27693619
[TBL] [Abstract][Full Text] [Related]
10. High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.
Mattu S; Saliba C; Sulas P; Zavattari P; Perra A; Kowalik MA; Monga SP; Columbano A
Am J Pathol; 2018 Nov; 188(11):2497-2507. PubMed ID: 30201494
[TBL] [Abstract][Full Text] [Related]
11. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
[TBL] [Abstract][Full Text] [Related]
13. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
[TBL] [Abstract][Full Text] [Related]
14. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
[TBL] [Abstract][Full Text] [Related]
15. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
16. Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway.
Geter DR; Bhat VS; Gollapudi BB; Sura R; Hester SD
Toxicol Sci; 2014 Apr; 138(2):425-45. PubMed ID: 24449422
[TBL] [Abstract][Full Text] [Related]
17. Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital.
Sidaway JE; Orton TC; Kalaitzi K; Jones HB; Foster A; Lake BG
Toxicology; 2020 Jan; 430():152343. PubMed ID: 31836555
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
20. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
Zhang Y; Liang B; Song X; Wang H; Evert M; Zhou Y; Calvisi DF; Tang L; Chen X
Am J Pathol; 2021 May; 191(5):930-946. PubMed ID: 33545120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
